Examination of human bladder, head and neck, and lung primary tumors reveal
ed a high frequency of mitochondrial DNA (mtDNA) mutations. The majority of
these somatic mutations were homoplasmic in nature, indicating that the mu
tant mtDNA became dominant in tumor cells. The mutated mtDNA was readily de
tectable in paired bodily fluids from each type of cancer and was 19 to 220
times as abundant as mutated nuclear p53 DNA. By virtue of their clonal na
ture and high copy number, mitochondrial mutations may provide a powerful m
olecular marker for noninvasive detection of cancer.